US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ACRES Commercial Realty Corp.

18.01

-0.0600-0.33%

Post-market: 18.010.00000.00%16:04 EDT

Volume:20.51K

Turnover:370.70K

Market Cap:133.17M

PE:52.49

High:18.22

Open:18.08

Low:17.96

Close:18.07

Loading ...

Overview Company News Filings

David J. Bryant, Director, Reports Disposal of Common Shares in Acres Commercial Realty Corp

Press Release: ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock

Acres Commercial Realty Corp. Held Annual Stockholders Meeting, Electing Directors and Approving Executive Compensation

De La Rue Shareholders Approve Acquisition by ACR Bidco Limited

Optimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer

Press Release: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results

Acres Commercial Realty Corp reports results for the quarter ended March 31 - Earnings Summary

ACRES Commercial Realty Q1 Adj. EPS $(0.86) Misses $0.53 Estimate, Sales $17.00M Miss $21.84M Estimate

Acres Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program

THOMSON REUTERS

Acres Commercial Realty Corp. Reports Results for First Quarter 2025

THOMSON REUTERS

Acres Commercial Realty Q1 Net Income USD -5.9 Million

THOMSON REUTERS

Press Release: ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR FIRST QUARTER 2025

Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States

Acres Commercial Realty Corp expected to post earnings of 53 cents a share - Earnings Preview

Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis

De La Rue Board Favors ACR Bidco Acquisition Amid Speculation

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates

ASUS Republic of Gamers Announces ROG Strix SCAR, Strix G18, and Zephyrus, Are Now Available and Shipping

Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","market":"US","secType":"STK","nameCN":"ACRES Commercial Realty Corp.","latestPrice":18.01,"timestamp":1749844800000,"preClose":18.07,"halted":0,"volume":20509,"hourTrading":{"tag":"盘后","latestPrice":18.01,"preClose":18.01,"latestTime":"16:04 EDT","volume":516,"amount":9293.160000000002,"timestamp":1749845054253},"delay":0,"floatShares":7394194,"shares":7394194,"eps":0.343106,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"06-13 18:55:39 EDT","open":18.08,"high":18.22,"low":17.96,"amount":370702.572314,"amplitude":0.014388,"askPrice":20.13,"askSize":100,"bidPrice":10.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.343106,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749859200000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":18.07,"postHourTrading":{"tag":"盘后","latestPrice":18.01,"preClose":18.01,"latestTime":"16:04 EDT","volume":516,"amount":9293.160000000002,"timestamp":1749845054253},"volumeRatio":0.608637,"impliedVol":0.41,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","floatShares":7394194,"roa":"1.18%","roe":"5.22%","lyrEps":1.191983,"volumeRatio":0.608637,"shares":7394194,"dividePrice":0,"high":18.22,"amplitude":0.014388,"preClose":18.07,"low":17.96,"week52Low":12.6,"pbRate":"0.31","psRate":"1.59","week52High":23.81,"institutionHeld":0.1962,"latestPrice":18.01,"eps":0.343106,"divideRate":0,"volume":20509,"delay":0,"ttmEps":0.343106,"open":18.08,"prevYearClose":16.15,"prevWeekClose":18.12,"prevMonthClose":18.91,"prevQuarterClose":21.67,"fiveDayClose":18.12,"twentyDayClose":18.77,"sixtyDayClose":23.53},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543963763","title":"David J. Bryant, Director, Reports Disposal of Common Shares in Acres Commercial Realty Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2543963763","media":"Reuters","labels":["shareholding","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2543963763?lang=en_us&edition=fundamental","pubTime":"2025-06-14 04:00","pubTimestamp":1749844843,"startTime":"0","endTime":"0","summary":"David J. Bryant, a Director of Acres Commercial Realty Corp., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acres Commercial Realty Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL6hx75Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"David J. Bryant, Director, Reports Disposal of Common Shares in Acres Commercial Realty Corp","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2541055820","title":"Press Release: ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2541055820","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541055820?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:10","pubTimestamp":1749154200,"startTime":"0","endTime":"0","summary":"UNIONDALE, N.Y., June 5, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp.   announced today that its Board of Directors declared cash dividends on its Preferred Stock.The Company will pay a cash dividend on its 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock  in the amount of $0.6379156 per share, which reflects a rate of 10.20665%, equal to three-month Term SOFR on the dividend determination date plus a spread of 5.927% per annum. The dividend will be payable on July 30, 2025, to holders of record on July 1, 2025.The Company will also pay a cash dividend on its 7.875% Series D Cumulative Redeemable Preferred Stock in the amount of $0.4921875 per share. The dividend will be payable on July 30, 2025, to holders of record on July 1, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2541005360","title":"Acres Commercial Realty Corp. Held Annual Stockholders Meeting, Electing Directors and Approving Executive Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=2541005360","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541005360?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:09","pubTimestamp":1749154167,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp. held its 2025 Annual Meeting of Stockholders on June 5, 2025. During the meeting, stockholders elected nine directors to the board. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified. All proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acres Commercial Realty Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL1LYXx5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2540774635","title":"De La Rue Shareholders Approve Acquisition by ACR Bidco Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2540774635","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540774635?lang=en_us&edition=fundamental","pubTime":"2025-06-03 20:52","pubTimestamp":1748955140,"startTime":"0","endTime":"0","summary":"The latest update is out from De La Rue ( ($GB:DLAR) ). De La Rue PLC has announced the approval of its acquisition by ACR Bidco Limited, a company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/de-la-rue-shareholders-approve-acquisition-by-acr-bidco-limited?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/de-la-rue-shareholders-approve-acquisition-by-acr-bidco-limited?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2535881434","title":"Optimistic Outlook for Acrivon Therapeutics: Promising ACR-368 Results and Strategic Focus on Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2535881434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535881434?lang=en_us&edition=fundamental","pubTime":"2025-05-15 06:45","pubTimestamp":1747262722,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm has maintained their bullish stance on ACRV stock, giving a Buy rating on May 5. Marc Frahm has given his Buy rating du...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/optimistic-outlook-for-acrivon-therapeutics-promising-acr-368-results-and-strategic-focus-on-endometrial-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/optimistic-outlook-for-acrivon-therapeutics-promising-acr-368-results-and-strategic-focus-on-endometrial-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4110","BK4139","ACR","BK4007","LENZ"],"gpt_icon":0},{"id":"2534892104","title":"Press Release: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534892104","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534892104?lang=en_us&edition=fundamental","pubTime":"2025-05-09 18:50","pubTimestamp":1746787800,"startTime":"0","endTime":"0","summary":"Company to host conference call and webcast today at 8:30 a.m. EDT. CARMIEL, Israel, May 9, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today reported financial results for the quarter ended March 31, 2025, and provided a business and clinical update.\"We had another solid quarter, with an increase in revenues from selling goods compared to the prior year quarter,\" said Dror Bashan, Protalix's President and Chief Executive Officer. \"Given the promising results obtained in 2024 from our first-in-human study of our gout candidate, PRX-115, we are focused on building on the momentum and working toward initiating a phase II clinical trial in patients with gout later this year. At the same time, we continued to evaluate additional pipeline candidates for potential further develo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE000M9KFDE8.USD","LU1057294990.SGD","IE00BLSP4239.USD","BK4568","R","LU1066051498.USD","LU1883839398.USD","SG9999013999.USD","BK4604","SGXZ57979304.SGD","LU0985481810.HKD","BK4585","IE00BLSP4452.SGD","LU0321505868.SGD","LU1066053197.SGD","03160","LU0225284248.USD","BK4232","LU0321505439.SGD","LU1023059063.AUD","PLX","BK4588","TM","LU0122379950.USD","BK4555","LU0868494617.USD","IE00B19Z3B42.SGD","LU1894683264.USD","LU1894683348.USD","BK4218","BK4599","LU0289739699.SGD","BK4099","BK4022","BK4581","LU0306807586.USD","LU0170899867.USD","LU0225771236.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002224.SGD","ACR","IE00B19Z3581.USD","SG9999002232.USD","PK","SG9999003800.SGD","SG9999011175.SGD","IE00BBT3K403.USD"],"gpt_icon":1},{"id":"2532924250","title":"Acres Commercial Realty Corp reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2532924250","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532924250?lang=en_us&edition=fundamental","pubTime":"2025-05-01 05:57","pubTimestamp":1746050270,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp reports results for the quarter ended March 31 - Earnings SummaryAcres Commercial Realty Corp ACR.N reported a quarterly adjusted loss of 86 cents per share for the quarte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL8N3R83GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR"],"gpt_icon":0},{"id":"2532095767","title":"ACRES Commercial Realty Q1 Adj. EPS $(0.86) Misses $0.53 Estimate, Sales $17.00M Miss $21.84M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2532095767","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532095767?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:26","pubTimestamp":1746044769,"startTime":"0","endTime":"0","summary":"ACRES Commercial Realty (NYSE:ACR) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $0.53 by 262.26 percent. This is a 637.5 percent decrease over earnings of $0.16 per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/45117996/acres-commercial-realty-q1-adj-eps-0-86-misses-0-53-estimate-sales-17-00m-miss-21-84m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR"],"gpt_icon":0},{"id":"2532930590","title":"Acres Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2532930590","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532930590?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:17","pubTimestamp":1746044223,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUA4RGVMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2532093501","title":"Acres Commercial Realty Corp. Reports Results for First Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532093501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532093501?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:10","pubTimestamp":1746043802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nTUAXJ5VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2532093529","title":"Acres Commercial Realty Q1 Net Income USD -5.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2532093529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532093529?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:10","pubTimestamp":1746043802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nPLX728CFD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2532009325","title":"Press Release: ACRES COMMERCIAL REALTY CORP. REPORTS RESULTS FOR FIRST QUARTER 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532009325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532009325?lang=en_us&edition=fundamental","pubTime":"2025-05-01 04:10","pubTimestamp":1746043800,"startTime":"0","endTime":"0","summary":"UNIONDALE, N.Y., April 30, 2025 /PRNewswire/ -- ACRES Commercial Realty Corp.  , a real estate investment trust that is primarily focused on originating, holding and managing commercial real estate mortgage loans and equity investments in commercial real estate property through direct ownership and joint ventures, today reported results for the quarter ended March 31, 2025. ACR's GAAP net loss allocable to common shares was $5.9 million or $ per share-diluted, for the quarter ended March 31, 2025.\"We remain confident in our ability to preserve and create value for our shareholders. During the quarter, we closed on a new financing facility to efficiently manage the liability side of our balance sheet,\" said Mark Fogel, President and Chief Executive Officer of ACRES Commercial Realty Corp. \"In addition, the team has been sourcing and underwriting high-quality loans to add to the portfolio, while continuing to aggressively manage our investments.\". This press release contains certain forw","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK4110","FOR","CFA.SI","BK4024","CORP","ACR"],"gpt_icon":0},{"id":"2531786662","title":"Cullinan Therapeutics to Initiate Study of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Sjögren’s Disease in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2531786662","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531786662?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:00","pubTimestamp":1745924400,"startTime":"0","endTime":"0","summary":"CLN-978 is the first and only development-stage CD19 T cell engager to receive U.S. FDA IND clearance in autoimmune diseases. Sjgren’s disease represents the third indication under development for CLN-978, and is a disease with high unmet need and no currently approved therapies. CAMBRIDGE, Mass., April 29, 2025  -- Cullinan Therapeutics, Inc., a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that the Company is initiating a study of CLN-978 in patients with Sjgren’s disease  in the U.S. The Company previously received U.S. Food and Drug Administration  Investigational New Drug  Application clearance to study the CD19 T cell engager in patients with moderate to severe systemic lupus erythematosus  and European Medicines Agency  approval to study CLN-978 in active, difficult-to-treat rheumatoid arthritis.“There are an estimated four million Americans living with Sjgren’s disease, yet it is underdiagnosed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-initiate-study-cln-110000913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4077","ACR","SLE","UBCP","BK4211","BK4110","CGEM","BK4139"],"gpt_icon":0},{"id":"2531719269","title":"Acres Commercial Realty Corp  expected to post earnings of 53 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2531719269","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531719269?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:01","pubTimestamp":1745874082,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp  expected to post earnings of53cents a share - Earnings Preview Acres Commercial Realty Corp ACR.N, ACR is expected to show a rise in quarterly revenue when it reports  re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL8N3R628B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR"],"gpt_icon":0},{"id":"2530187641","title":"Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530187641","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530187641?lang=en_us&edition=fundamental","pubTime":"2025-04-25 20:00","pubTimestamp":1745582400,"startTime":"0","endTime":"0","summary":"Presentation to highlight how AP3 Generative Phosphoproteomic analyses uncover how ACR-2316 induces mitotic and replicative tumor cell death, and the mechanisms underlying its superior potency observed preclinically. Phase 1 trial of ACR-2316 ahead of schedule with three dose-escalation cohorts completed; solid tumor shrinkage already observed at dose level three, well below the projected recommended Phase 2 dose. “ACR-2316 was rationally designed through AP3-based SAR to induce desirable anti-tumor pathway effects inside a cell and to overcome the limitations of single-target WEE1 and PKMYT1 inhibitors. Our Phase 1 study of ACR-2316 is advancing rapidly, and we are excited about these encouraging observations, including early clinical activity,” said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon Therapeutics. “Uniquely enabled by our Generative Phosphoproteomics AP3 platform, ACR-2316 is optimized to achieve superior single-agent activity,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acrivon-therapeutics-reveal-molecular-mechanisms-120000701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ACRV","SSI","BK4139","LENZ","ACR","BK4007","BK4110"],"gpt_icon":0},{"id":"2527629431","title":"Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2527629431","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527629431?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:00","pubTimestamp":1744801200,"startTime":"0","endTime":"0","summary":"Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025. CLN-978 is also being studied in the U.S., Europe, and Australia for systemic lupus erythematosus. About CLN-978CLN-978 is a novel, differentiated and highly potent CD19xCD3 bispecific T cell engager. CLN-978 triggers redirected lysis of CD19-expressing target cellsin vitroandin vivo. CLN-978 is engineered to achieve very high affinity binding to CD19 to efficiently target B cells, including those with very low CD19 levels. Small in molecular size , CLN-978 contains two single-chain variable fragments, one b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cullinan-therapeutics-receives-approval-european-110000424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4110","BK4139","ACR","CTA","CGEM","MDCO"],"gpt_icon":0},{"id":"2527464021","title":"De La Rue Board Favors ACR Bidco Acquisition Amid Speculation","url":"https://stock-news.laohu8.com/highlight/detail?id=2527464021","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527464021?lang=en_us&edition=fundamental","pubTime":"2025-04-15 17:37","pubTimestamp":1744709839,"startTime":"0","endTime":"0","summary":"De La Rue ( ($GB:DLAR) ) has provided an update. De La Rue PLC has been in discussions with Disruptive Capital GP Limited and Pension SuperFund Cap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/de-la-rue-board-favors-acr-bidco-acquisition-amid-speculation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/de-la-rue-board-favors-acr-bidco-acquisition-amid-speculation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2524230326","title":"MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2524230326","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524230326?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:00","pubTimestamp":1743678000,"startTime":"0","endTime":"0","summary":"Agreement with Hercules Capital significantly increases financial and operational strength, provides up to $500 million in capital with no dilution to shareholders, an attractive cost of capital and l","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/03/3054971/0/en/MoonLake-Secures-up-to-500-Million-in-Non-Dilutive-Financing-from-Hercules-Capital-and-Announces-a-Capital-Markets-Update-on-April-29-to-Provide-Important-Clinical-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","HTGC","LU1169590202.USD","LU1169589451.USD","AN","BK4214","MDA","BK4110","ACR"],"gpt_icon":0},{"id":"2523182940","title":"ASUS Republic of Gamers Announces ROG Strix SCAR, Strix G18, and Zephyrus, Are Now Available and Shipping","url":"https://stock-news.laohu8.com/highlight/detail?id=2523182940","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523182940?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:39","pubTimestamp":1743428340,"startTime":"0","endTime":"0","summary":"ROG begins shipping the next generation RTX 50 Series of Laptop GPU equipped devices. FREMONT, Calif., March 31, 2025 /PRNewswire/ --ASUS Republic of Gamers  today announced that it has begun shipping their much-anticipated NVIDIA GeForce RTX Series equipped line-up of laptops after initial unveil at CES 2025 subsequent pre-order on February 25, 2025. ASUS ROG's line up of GeForce RTX Series Laptop GPUs include: ROG Strix SCAR 16 and SCAR 18; ROG Strix G18; and ROG Zephyrus G14 and G16. Featuring the latest cutting-edge silicon from Intel and NVIDIA, our portable line up is designed to deliver the power and performance that gamers can expect without compromise.Both models are equipped with dual PCIe Gen 4.0 SSD slots and designed for tool-less access, with Intel models supporting PCIe Gen 5 on both slots this allows for seamless storage upgrades.With customizable hotkey","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/asus-republic-gamers-announces-rog-133900300.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asus-republic-gamers-announces-rog-133900300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2275660780.HKD","GB00BDT5M118.USD","3NVD.UK","ASUUY","LU1564329032.USD","LU1670628061.USD","SD","NVDS.UK","LU2720916845.USD","ACR","RTX","LU1043141123.HKD","LU0308772762.SGD","LU2404859667.USD","NVD","LU0149725797.USD","SNVD.UK","USB","LU0130102774.USD","GEN","NVD2.UK","NVDU","NVDX","LU1951198990.SGD","LU1935042488.USD","LU2092937221.SGD","LU2125154935.USD","NVD3.UK","ROG","BK4548","LU1934455277.USD","NVDY","HK0000306685.HKD","LU2237443549.SGD","USAW.SI","2NVD.UK","LU1852331112.SGD","NVIW.SI","LU2506952170.USD","LU2265009873.SGD","LU1670627923.USD","NVDS","LU2237443382.USD","NVDD","SDR"],"gpt_icon":1},{"id":"2522821124","title":"Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522821124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522821124?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:16","pubTimestamp":1742984206,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar has maintained their bullish stance on ACRV stock, giving a Buy rating today. Emily Bodnar’s rating is based o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-for-acr-368-in-endometrial-cancer-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-2-results-for-acr-368-in-endometrial-cancer-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-30","symbol":"ACR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":-0.97},{"market":"US","date":"2025-03-05","symbol":"ACR","fiscalQuarterEnding":"2024/12","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2024-10-30","symbol":"ACR","fiscalQuarterEnding":"2024/09","expectedEps":0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.14},{"date":"2024-07-31","symbol":"ACR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":0.28,"defaultRemindTime":1722456000000,"name":null,"time":"Post Market","dateTimestamp":1722398400000,"actualEps":null},{"date":"2024-05-01","symbol":"ACR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/03","expectedEps":0.35,"defaultRemindTime":1714593600000,"name":null,"time":"Post Market","dateTimestamp":1714536000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-26","recordDate":"2015-06-30","paymentDate":"2015-07-28","value":0.16,"currency":"USD"},{"executeDate":"2015-09-28","recordDate":"2015-09-30","paymentDate":"2015-10-28","value":0.64,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-28","value":0.42,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-28","value":0.42,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-28","value":0.42,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1728360000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACR","date":"2025-06-12","current":5.224981,"percent":0.697315,"low":-0.773314,"twenty":2.413836,"median":4.196466,"eighty":5.92678,"high":14.204017,"avg":3.970697,"sd":3.058339,"marketCap":123231183},"quantilePoints":[{"date":"2020-06-19","current":-0.49784,"twenty":2.128917,"median":4.313896,"eighty":23.595809,"marketCap":83979610},{"date":"2020-06-26","current":-0.482811,"twenty":1.847407,"median":4.307872,"eighty":23.582109,"marketCap":81444376},{"date":"2020-07-02","current":-0.452752,"twenty":1.820352,"median":4.29783,"eighty":23.582109,"marketCap":76373909},{"date":"2020-07-10","current":-0.447117,"twenty":1.812445,"median":4.281763,"eighty":23.567545,"marketCap":75423197},{"date":"2020-07-17","current":-0.454631,"twenty":1.79588,"median":4.247621,"eighty":23.561875,"marketCap":76690813},{"date":"2020-07-24","current":-0.450874,"twenty":1.778891,"median":4.229546,"eighty":23.561368,"marketCap":76057005},{"date":"2020-07-31","current":-0.418937,"twenty":1.77303,"median":4.197413,"eighty":23.561368,"marketCap":70669634},{"date":"2020-08-07","current":-0.389478,"twenty":1.767642,"median":4.169297,"eighty":23.561368,"marketCap":82171619},{"date":"2020-08-14","current":-0.373121,"twenty":1.763277,"median":4.142325,"eighty":23.555746,"marketCap":78720623},{"date":"2020-08-21","current":-0.356571,"twenty":1.753473,"median":4.14118,"eighty":23.545397,"marketCap":75228983},{"date":"2020-08-28","current":-0.353562,"twenty":1.748369,"median":4.135155,"eighty":23.541135,"marketCap":74594139},{"date":"2020-09-04","current":-0.330994,"twenty":1.739311,"median":4.12913,"eighty":23.540628,"marketCap":69832811},{"date":"2020-09-11","current":-0.321967,"twenty":1.735731,"median":4.11708,"eighty":23.528183,"marketCap":67928280},{"date":"2020-09-18","current":-0.315949,"twenty":1.729507,"median":4.088963,"eighty":23.515678,"marketCap":66658592},{"date":"2020-09-25","current":-0.303913,"twenty":1.724061,"median":4.08093,"eighty":23.512872,"marketCap":64119217},{"date":"2020-10-02","current":-0.335508,"twenty":1.721155,"median":4.062855,"eighty":23.505565,"marketCap":70785077},{"date":"2020-10-09","current":-0.349048,"twenty":1.709118,"median":4.024697,"eighty":23.499765,"marketCap":73641873},{"date":"2020-10-16","current":-0.314444,"twenty":1.6899,"median":3.49084,"eighty":23.48763,"marketCap":66341170},{"date":"2020-10-23","current":-0.303913,"twenty":1.680487,"median":2.92946,"eighty":23.479024,"marketCap":64119217},{"date":"2020-10-30","current":-0.28285,"twenty":1.671636,"median":2.901471,"eighty":23.474204,"marketCap":59675311},{"date":"2020-11-06","current":-0.317044,"twenty":1.669001,"median":2.893012,"eighty":23.46316,"marketCap":68283910},{"date":"2020-11-13","current":-0.410817,"twenty":1.660341,"median":2.891803,"eighty":23.457665,"marketCap":88480560},{"date":"2020-11-20","current":-0.482264,"twenty":1.638881,"median":2.890595,"eighty":23.453467,"marketCap":103868483},{"date":"2020-11-27","current":-0.55371,"twenty":1.628025,"median":2.888178,"eighty":23.445171,"marketCap":119256407},{"date":"2020-12-04","current":-0.614737,"twenty":1.126039,"median":2.87972,"eighty":23.434129,"marketCap":132400258},{"date":"2020-12-11","current":-0.584968,"twenty":-0.285558,"median":2.864009,"eighty":23.429934,"marketCap":125988623},{"date":"2020-12-18","current":-0.580502,"twenty":-0.300302,"median":2.849508,"eighty":23.424434,"marketCap":125026878},{"date":"2020-12-24","current":-0.601341,"twenty":-0.300904,"median":2.831381,"eighty":23.416184,"marketCap":129515022},{"date":"2020-12-31","current":-0.593899,"twenty":-0.303913,"median":2.820506,"eighty":23.416184,"marketCap":127912114},{"date":"2021-01-08","current":-0.640041,"twenty":-0.314444,"median":2.798754,"eighty":23.409199,"marketCap":137850148},{"date":"2021-01-15","current":-0.596876,"twenty":-0.317044,"median":2.779419,"eighty":23.409199,"marketCap":128553277},{"date":"2021-01-22","current":-0.626645,"twenty":-0.321601,"median":2.768543,"eighty":23.407301,"marketCap":134964912},{"date":"2021-01-29","current":-0.59241,"twenty":-0.325277,"median":2.721413,"eighty":23.39772,"marketCap":127591532},{"date":"2021-02-05","current":-0.59241,"twenty":-0.327985,"median":2.702078,"eighty":23.395443,"marketCap":127591532},{"date":"2021-02-12","current":-0.601341,"twenty":-0.329791,"median":2.692411,"eighty":23.395443,"marketCap":129515022},{"date":"2021-02-19","current":-0.538901,"twenty":-0.336712,"median":2.68516,"eighty":23.382999,"marketCap":116066912},{"date":"2021-02-26","current":-0.585684,"twenty":-0.343632,"median":2.668242,"eighty":23.374703,"marketCap":126142837},{"date":"2021-03-05","current":-0.656758,"twenty":-0.34965,"median":2.65374,"eighty":23.37052,"marketCap":141450494},{"date":"2021-03-12","current":-0.765058,"twenty":-0.355066,"median":2.642864,"eighty":23.367731,"marketCap":151261945},{"date":"2021-03-19","current":-0.773314,"twenty":-0.359667,"median":2.636822,"eighty":23.366463,"marketCap":152894262},{"date":"2021-03-26","current":-0.730698,"twenty":-0.372029,"median":2.628363,"eighty":23.358624,"marketCap":144468510},{"date":"2021-04-01","current":-0.728783,"twenty":-0.374023,"median":2.619904,"eighty":23.353962,"marketCap":144089825},{"date":"2021-04-09","current":-0.733571,"twenty":-0.377896,"median":2.605403,"eighty":23.351176,"marketCap":145036538},{"date":"2021-04-16","current":-0.733507,"twenty":-0.38625,"median":2.600569,"eighty":23.341486,"marketCap":145023804},{"date":"2021-04-23","current":-0.728759,"twenty":-0.394383,"median":2.571519,"eighty":23.333221,"marketCap":144085138},{"date":"2021-04-30","current":-0.716127,"twenty":-0.403156,"median":2.562972,"eighty":23.333221,"marketCap":141587548},{"date":"2021-05-07","current":12.280556,"twenty":-0.403908,"median":2.564193,"eighty":23.325539,"marketCap":145696522},{"date":"2021-05-14","current":11.159187,"twenty":-0.403156,"median":2.571519,"eighty":23.313402,"marketCap":132392591},{"date":"2021-05-21","current":12.000214,"twenty":-0.401278,"median":2.600569,"eighty":23.309699,"marketCap":142370539},{"date":"2021-05-28","current":12.008001,"twenty":-0.399569,"median":2.605403,"eighty":23.297233,"marketCap":142462928},{"date":"2021-06-04","current":12.880178,"twenty":-0.397861,"median":2.619904,"eighty":23.282034,"marketCap":152810430},{"date":"2021-06-11","current":13.61997,"twenty":-0.394449,"median":2.629572,"eighty":23.269611,"marketCap":161587329},{"date":"2021-06-18","current":13.253968,"twenty":-0.393243,"median":2.638031,"eighty":23.261298,"marketCap":157245073},{"date":"2021-06-25","current":13.191669,"twenty":-0.389358,"median":2.644073,"eighty":23.248872,"marketCap":156505966},{"date":"2021-07-02","current":12.545324,"twenty":-0.388504,"median":2.655244,"eighty":23.240563,"marketCap":148837728},{"date":"2021-07-09","current":12.958051,"twenty":-0.387002,"median":2.668242,"eighty":23.229518,"marketCap":153734314},{"date":"2021-07-16","current":12.630985,"twenty":-0.385121,"median":2.68516,"eighty":23.229518,"marketCap":149854001},{"date":"2021-07-23","current":12.919114,"twenty":-0.385121,"median":2.696036,"eighty":23.229518,"marketCap":153272372},{"date":"2021-07-30","current":13.627758,"twenty":-0.378951,"median":2.704495,"eighty":23.222589,"marketCap":161679717},{"date":"2021-08-06","current":2.692645,"twenty":-0.378071,"median":2.712954,"eighty":23.210305,"marketCap":158604894},{"date":"2021-08-13","current":2.590862,"twenty":-0.377634,"median":2.699661,"eighty":23.201855,"marketCap":152609520},{"date":"2021-08-20","current":2.612452,"twenty":-0.375728,"median":2.692528,"eighty":23.188037,"marketCap":153881266},{"date":"2021-08-27","current":2.524548,"twenty":-0.374625,"median":2.68516,"eighty":23.18112,"marketCap":148703443},{"date":"2021-09-03","current":2.529174,"twenty":-0.374625,"median":2.668242,"eighty":23.18112,"marketCap":148975960},{"date":"2021-09-10","current":2.444355,"twenty":-0.373422,"median":2.655244,"eighty":23.164533,"marketCap":143979815},{"date":"2021-09-17","current":2.424306,"twenty":-0.373121,"median":2.644073,"eighty":23.160386,"marketCap":142798908},{"date":"2021-09-24","current":2.478282,"twenty":-0.372318,"median":2.638031,"eighty":23.160386,"marketCap":145978273},{"date":"2021-10-01","current":2.530717,"twenty":-0.372,"median":2.630356,"eighty":23.160386,"marketCap":149066799},{"date":"2021-10-08","current":2.432017,"twenty":-0.36928,"median":2.624738,"eighty":23.127211,"marketCap":143253103},{"date":"2021-10-15","current":2.422764,"twenty":-0.367258,"median":2.617487,"eighty":23.118917,"marketCap":142708069},{"date":"2021-10-22","current":2.422764,"twenty":-0.362252,"median":2.608928,"eighty":23.109059,"marketCap":142708069},{"date":"2021-10-29","current":2.421222,"twenty":-0.359194,"median":2.602389,"eighty":23.099865,"marketCap":142617230},{"date":"2021-11-05","current":2.948349,"twenty":-0.357001,"median":2.601479,"eighty":23.065008,"marketCap":135081545},{"date":"2021-11-12","current":2.972158,"twenty":-0.356571,"median":2.605403,"eighty":23.045624,"marketCap":136172379},{"date":"2021-11-19","current":2.906683,"twenty":-0.355367,"median":2.614969,"eighty":23.037354,"marketCap":133172587},{"date":"2021-11-26","current":2.84716,"twenty":-0.355066,"median":2.621242,"eighty":23.035979,"marketCap":130445503},{"date":"2021-12-03","current":2.698354,"twenty":-0.354164,"median":2.629572,"eighty":23.023539,"marketCap":123627794},{"date":"2021-12-10","current":2.672561,"twenty":-0.353562,"median":2.636203,"eighty":23.015245,"marketCap":122446058},{"date":"2021-12-17","current":2.432487,"twenty":-0.351757,"median":2.629572,"eighty":23.015245,"marketCap":111446820},{"date":"2021-12-23","current":2.45828,"twenty":-0.349951,"median":2.622321,"eighty":23.001399,"marketCap":112628556},{"date":"2021-12-31","current":2.474153,"twenty":-0.348446,"median":2.614969,"eighty":22.97803,"marketCap":113355779},{"date":"2022-01-07","current":2.45828,"twenty":-0.34634,"median":2.605403,"eighty":22.973988,"marketCap":112628556},{"date":"2022-01-14","current":2.628911,"twenty":-0.344535,"median":2.605403,"eighty":22.973776,"marketCap":120446196},{"date":"2022-01-21","current":2.41463,"twenty":-0.344234,"median":2.601479,"eighty":22.969629,"marketCap":110628695},{"date":"2022-01-28","current":2.329315,"twenty":-0.342428,"median":2.593946,"eighty":22.948894,"marketCap":106719875},{"date":"2022-02-04","current":2.416614,"twenty":-0.33972,"median":2.588548,"eighty":22.928309,"marketCap":110719598},{"date":"2022-02-11","current":2.402726,"twenty":-0.338517,"median":2.584693,"eighty":22.90988,"marketCap":110083278},{"date":"2022-02-18","current":2.333283,"twenty":-0.337915,"median":2.570395,"eighty":22.898273,"marketCap":106901681},{"date":"2022-02-25","current":2.245983,"twenty":-0.335508,"median":2.564193,"eighty":22.890838,"marketCap":102901958},{"date":"2022-03-04","current":3.243244,"twenty":-0.330994,"median":2.564193,"eighty":22.871107,"marketCap":110020560},{"date":"2022-03-11","current":3.039484,"twenty":-0.330994,"median":2.570395,"eighty":22.849369,"marketCap":103108427},{"date":"2022-03-18","current":3.155514,"twenty":-0.32949,"median":2.584693,"eighty":22.828635,"marketCap":107044517},{"date":"2022-03-25","current":3.422888,"twenty":-0.32949,"median":2.588548,"eighty":22.828635,"marketCap":116114636},{"date":"2022-04-01","current":3.397664,"twenty":-0.328951,"median":2.593946,"eighty":22.827656,"marketCap":115258964},{"date":"2022-04-08","current":3.274067,"twenty":-0.327985,"median":2.601479,"eighty":22.8079,"marketCap":111066173},{"date":"2022-04-14","current":3.248843,"twenty":-0.327985,"median":2.605403,"eighty":22.791313,"marketCap":110210502},{"date":"2022-04-22","current":3.127915,"twenty":-0.327985,"median":2.612452,"eighty":22.72819,"marketCap":106108277},{"date":"2022-04-29","current":2.868089,"twenty":-0.326782,"median":2.621242,"eighty":22.688706,"marketCap":97294170},{"date":"2022-05-06","current":4.375842,"twenty":-0.326481,"median":2.628911,"eighty":22.657479,"marketCap":100429958},{"date":"2022-05-13","current":4.21343,"twenty":-0.325277,"median":2.630625,"eighty":22.634624,"marketCap":96702425},{"date":"2022-05-20","current":3.735933,"twenty":-0.322569,"median":2.636822,"eighty":22.60654,"marketCap":85743401},{"date":"2022-05-27","current":3.743573,"twenty":-0.321967,"median":2.642864,"eighty":22.591302,"marketCap":85918746},{"date":"2022-06-03","current":3.785593,"twenty":-0.321967,"median":2.651324,"eighty":22.545587,"marketCap":86883140},{"date":"2022-06-10","current":3.678634,"twenty":-0.321692,"median":2.668242,"eighty":22.48538,"marketCap":84428318},{"date":"2022-06-17","current":3.224057,"twenty":-0.320881,"median":2.67161,"eighty":22.421163,"marketCap":73995328},{"date":"2022-06-24","current":3.193497,"twenty":-0.319259,"median":2.686797,"eighty":22.367371,"marketCap":73293950},{"date":"2022-07-01","current":3.304276,"twenty":-0.317289,"median":2.691936,"eighty":22.325763,"marketCap":75836444},{"date":"2022-07-08","current":3.227877,"twenty":-0.316825,"median":2.692645,"eighty":22.317329,"marketCap":74083000},{"date":"2022-07-15","current":2.998678,"twenty":-0.315949,"median":2.699661,"eighty":22.30517,"marketCap":68822669},{"date":"2022-07-22","current":3.055978,"twenty":-0.315949,"median":2.704495,"eighty":22.284437,"marketCap":70137752},{"date":"2022-07-29","current":3.174397,"twenty":-0.315648,"median":2.716828,"eighty":22.263703,"marketCap":72855589},{"date":"2022-08-05","current":5.232925,"twenty":-0.314444,"median":2.726247,"eighty":22.238823,"marketCap":77625212},{"date":"2022-08-12","current":5.466621,"twenty":-0.314444,"median":2.760853,"eighty":22.205649,"marketCap":81091851},{"date":"2022-08-19","current":5.438471,"twenty":-0.312338,"median":2.772168,"eighty":22.201502,"marketCap":80674282},{"date":"2022-08-26","current":5.815674,"twenty":-0.303913,"median":2.785945,"eighty":22.182759,"marketCap":86269703},{"date":"2022-09-02","current":5.460991,"twenty":-0.303612,"median":2.798754,"eighty":22.174132,"marketCap":81008337},{"date":"2022-09-09","current":5.427211,"twenty":-0.302408,"median":2.815672,"eighty":22.174132,"marketCap":80507255},{"date":"2022-09-16","current":5.179496,"twenty":-0.300904,"median":2.822922,"eighty":22.164182,"marketCap":76832650},{"date":"2022-09-23","current":4.898002,"twenty":-0.300904,"median":2.831036,"eighty":22.164182,"marketCap":72656962},{"date":"2022-09-30","current":4.588358,"twenty":-0.300904,"median":2.842292,"eighty":22.164182,"marketCap":68063706},{"date":"2022-10-07","current":4.802294,"twenty":-0.300904,"median":2.861593,"eighty":22.122715,"marketCap":71237228},{"date":"2022-10-14","current":4.644657,"twenty":-0.300904,"median":2.866049,"eighty":22.122715,"marketCap":68898843},{"date":"2022-10-21","current":4.802294,"twenty":-0.299399,"median":2.878511,"eighty":22.101982,"marketCap":71237228},{"date":"2022-10-28","current":5.731225,"twenty":-0.297895,"median":2.885762,"eighty":22.101982,"marketCap":85016997},{"date":"2022-11-04","current":5.658037,"twenty":-0.294886,"median":2.890595,"eighty":22.081248,"marketCap":83931318},{"date":"2022-11-11","current":3.269547,"twenty":-0.287363,"median":2.891803,"eighty":22.060514,"marketCap":82896095},{"date":"2022-11-18","current":3.224437,"twenty":-0.28285,"median":2.893012,"eighty":22.039781,"marketCap":81752380},{"date":"2022-11-25","current":3.264743,"twenty":-0.281646,"median":2.900263,"eighty":22.039781,"marketCap":82774284},{"date":"2022-12-02","current":3.208315,"twenty":-0.278938,"median":2.909515,"eighty":22.039781,"marketCap":81343618},{"date":"2022-12-09","current":3.027746,"twenty":0.690334,"median":2.920572,"eighty":22.023194,"marketCap":76765484},{"date":"2022-12-16","current":2.937462,"twenty":1.319576,"median":2.928984,"eighty":21.985873,"marketCap":74476418},{"date":"2022-12-23","current":2.498939,"twenty":1.458571,"median":2.923052,"eighty":21.878059,"marketCap":63358094},{"date":"2022-12-30","current":2.663385,"twenty":1.56152,"median":2.918116,"eighty":21.803418,"marketCap":67527465},{"date":"2023-01-06","current":2.889096,"twenty":1.56152,"median":2.920572,"eighty":21.803418,"marketCap":73250132},{"date":"2023-01-13","current":3.121255,"twenty":1.56152,"median":2.934238,"eighty":21.803418,"marketCap":79136303},{"date":"2023-01-20","current":3.163173,"twenty":1.56152,"median":2.940687,"eighty":21.803418,"marketCap":80199084},{"date":"2023-01-27","current":3.03742,"twenty":1.56152,"median":2.963813,"eighty":21.803418,"marketCap":77010741},{"date":"2023-02-03","current":3.089011,"twenty":1.56152,"median":2.97938,"eighty":21.803418,"marketCap":78318780},{"date":"2023-02-10","current":2.995502,"twenty":1.56152,"median":2.986046,"eighty":21.803418,"marketCap":75947961},{"date":"2023-02-17","current":3.069664,"twenty":1.56152,"median":2.995967,"eighty":21.803418,"marketCap":77828265},{"date":"2023-02-24","current":3.101909,"twenty":1.56152,"median":3.006318,"eighty":21.803418,"marketCap":78645789},{"date":"2023-03-03","current":7.166438,"twenty":1.56152,"median":3.021298,"eighty":21.803418,"marketCap":76129066},{"date":"2023-03-10","current":6.673589,"twenty":1.565877,"median":3.03742,"eighty":21.803418,"marketCap":70893541},{"date":"2023-03-17","current":6.627828,"twenty":1.596379,"median":3.047969,"eighty":21.803418,"marketCap":70407414},{"date":"2023-03-24","current":7.581198,"twenty":1.601086,"median":3.061417,"eighty":21.803418,"marketCap":80535062},{"date":"2023-03-31","current":7.413404,"twenty":1.645072,"median":3.077506,"eighty":21.786831,"marketCap":78752596},{"date":"2023-04-06","current":7.192223,"twenty":1.601086,"median":3.08741,"eighty":21.803418,"marketCap":76402982},{"date":"2023-04-14","current":7.390524,"twenty":1.5571,"median":3.105133,"eighty":21.820005,"marketCap":78509533},{"date":"2023-04-21","current":7.375972,"twenty":1.513114,"median":3.121255,"eighty":21.836592,"marketCap":78354950},{"date":"2023-04-28","current":6.610326,"twenty":1.469128,"median":3.128557,"eighty":21.853179,"marketCap":70221497},{"date":"2023-05-05","current":6.094842,"twenty":1.469128,"median":3.146532,"eighty":21.853179,"marketCap":64745508},{"date":"2023-05-12","current":6.315875,"twenty":1.469128,"median":3.161027,"eighty":21.853179,"marketCap":69335675},{"date":"2023-05-19","current":6.24252,"twenty":1.469128,"median":3.171711,"eighty":21.853179,"marketCap":68530383},{"date":"2023-05-26","current":5.892774,"twenty":1.469128,"median":3.174891,"eighty":21.853179,"marketCap":64690871},{"date":"2023-06-02","current":6.111565,"twenty":1.469128,"median":3.178756,"eighty":21.853179,"marketCap":67092760},{"date":"2023-06-09","current":6.149999,"twenty":1.469128,"median":3.189323,"eighty":21.853179,"marketCap":67514692},{"date":"2023-06-16","current":6.082393,"twenty":1.469128,"median":3.199227,"eighty":21.853179,"marketCap":66772508},{"date":"2023-06-23","current":6.049574,"twenty":1.458571,"median":3.208315,"eighty":21.878059,"marketCap":66412225},{"date":"2023-06-30","current":6.257426,"twenty":1.448015,"median":3.216397,"eighty":21.902939,"marketCap":68694019},{"date":"2023-07-07","current":6.250133,"twenty":1.448015,"median":3.224292,"eighty":21.902939,"marketCap":68613956},{"date":"2023-07-14","current":6.578319,"twenty":1.448015,"median":3.243521,"eighty":21.902939,"marketCap":72216789},{"date":"2023-07-21","current":6.702301,"twenty":1.448015,"median":3.24834,"eighty":21.902939,"marketCap":73577860},{"date":"2023-07-28","current":6.578319,"twenty":1.448015,"median":3.264991,"eighty":21.902939,"marketCap":72216789},{"date":"2023-08-04","current":6.184495,"twenty":1.448015,"median":3.286333,"eighty":21.902939,"marketCap":67893390},{"date":"2023-08-11","current":6.351685,"twenty":1.448015,"median":3.322273,"eighty":21.902939,"marketCap":70535467},{"date":"2023-08-18","current":6.122833,"twenty":1.448015,"median":3.390097,"eighty":21.902939,"marketCap":67994059},{"date":"2023-08-25","current":6.050115,"twenty":1.448015,"median":3.429194,"eighty":21.902939,"marketCap":67186529},{"date":"2023-09-01","current":6.166463,"twenty":1.448015,"median":3.730203,"eighty":21.902939,"marketCap":68478577},{"date":"2023-09-08","current":5.810147,"twenty":1.448015,"median":3.743573,"eighty":21.902939,"marketCap":64521678},{"date":"2023-09-15","current":6.006485,"twenty":1.448015,"median":3.764583,"eighty":21.902939,"marketCap":66702011},{"date":"2023-09-22","current":5.868321,"twenty":1.448015,"median":4.024697,"eighty":21.902939,"marketCap":65167703},{"date":"2023-09-29","current":5.991941,"twenty":1.448015,"median":4.078921,"eighty":21.902939,"marketCap":66540504},{"date":"2023-10-06","current":5.970126,"twenty":1.448015,"median":4.113063,"eighty":21.902939,"marketCap":66298245},{"date":"2023-10-13","current":5.82469,"twenty":1.448015,"median":4.135155,"eighty":21.902939,"marketCap":64683185},{"date":"2023-10-20","current":5.263018,"twenty":1.448015,"median":4.142325,"eighty":21.902939,"marketCap":58445820},{"date":"2023-10-27","current":5.453103,"twenty":1.416345,"median":4.14118,"eighty":21.97758,"marketCap":60556704},{"date":"2023-11-03","current":5.639187,"twenty":1.416345,"median":4.14118,"eighty":14.071633,"marketCap":62623174},{"date":"2023-11-10","current":4.597236,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60968545},{"date":"2023-11-17","current":4.691483,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":62218453},{"date":"2023-11-24","current":4.594442,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60931496},{"date":"2023-12-01","current":4.552014,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60368804},{"date":"2023-12-08","current":5.091467,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":67523030},{"date":"2023-12-15","current":5.430898,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":72024565},{"date":"2023-12-22","current":6.121882,"twenty":1.426902,"median":4.144334,"eighty":13.959496,"marketCap":81188405},{"date":"2023-12-29","current":5.921861,"twenty":1.416345,"median":4.173313,"eighty":13.99376,"marketCap":78535715},{"date":"2024-01-05","current":5.994596,"twenty":1.319576,"median":4.201799,"eighty":14.009335,"marketCap":79500329},{"date":"2024-01-12","current":6.030963,"twenty":1.319576,"median":4.247621,"eighty":14.009335,"marketCap":79982637},{"date":"2024-01-19","current":5.897615,"twenty":1.222807,"median":4.282189,"eighty":14.024909,"marketCap":78214176},{"date":"2024-01-26","current":5.909738,"twenty":1.319576,"median":4.311888,"eighty":14.009335,"marketCap":78374946},{"date":"2024-02-02","current":6.079454,"twenty":1.319576,"median":4.327955,"eighty":14.009335,"marketCap":80625713},{"date":"2024-02-09","current":5.976412,"twenty":1.319576,"median":4.350046,"eighty":14.009335,"marketCap":79259176},{"date":"2024-02-16","current":6.085515,"twenty":1.319576,"median":4.362096,"eighty":14.009335,"marketCap":80706098},{"date":"2024-02-23","current":6.321904,"twenty":1.319576,"median":4.386196,"eighty":14.009335,"marketCap":83841096},{"date":"2024-03-01","current":6.697703,"twenty":1.416345,"median":4.576259,"eighty":13.99376,"marketCap":88824938},{"date":"2024-03-08","current":3.802021,"twenty":1.416345,"median":4.594442,"eighty":13.99376,"marketCap":85127249},{"date":"2024-03-15","current":3.670771,"twenty":1.416345,"median":4.552014,"eighty":13.627758,"marketCap":82188558},{"date":"2024-03-22","current":4.518879,"twenty":1.416345,"median":4.374799,"eighty":13.542097,"marketCap":101177708},{"date":"2024-03-28","current":4.473036,"twenty":1.416345,"median":4.324209,"eighty":13.253968,"marketCap":100151267},{"date":"2024-04-05","current":4.548166,"twenty":1.319576,"median":4.316791,"eighty":13.048383,"marketCap":101833436},{"date":"2024-04-12","current":4.421557,"twenty":1.319576,"median":4.316791,"eighty":12.951821,"marketCap":98998672},{"date":"2024-04-19","current":4.434543,"twenty":1.319576,"median":4.316791,"eighty":12.824109,"marketCap":99289417},{"date":"2024-04-26","current":4.434543,"twenty":1.416345,"median":4.324209,"eighty":12.732219,"marketCap":99289417},{"date":"2024-05-03","current":4.212125,"twenty":1.416345,"median":4.309328,"eighty":12.514175,"marketCap":94309475},{"date":"2024-05-10","current":3.932803,"twenty":1.416345,"median":4.212125,"eighty":12.280556,"marketCap":98662220},{"date":"2024-05-17","current":3.918344,"twenty":1.416345,"median":4.14347,"eighty":12.078087,"marketCap":98299491},{"date":"2024-05-24","current":3.756405,"twenty":1.416345,"median":3.988402,"eighty":12.000214,"marketCap":94236929},{"date":"2024-05-31","current":3.606033,"twenty":1.416345,"median":3.918344,"eighty":11.314932,"marketCap":90464550},{"date":"2024-06-07","current":3.788005,"twenty":1.416345,"median":3.860508,"eighty":9.717873,"marketCap":95029691},{"date":"2024-06-14","current":3.851139,"twenty":1.319576,"median":3.804358,"eighty":7.887548,"marketCap":96613519},{"date":"2024-06-21","current":3.893228,"twenty":1.222807,"median":3.802673,"eighty":7.521707,"marketCap":97669405},{"date":"2024-06-28","current":3.839113,"twenty":0.932501,"median":3.800901,"eighty":7.413404,"marketCap":96311838},{"date":"2024-07-05","current":3.953355,"twenty":0.932501,"median":3.800901,"eighty":7.375972,"marketCap":99177812},{"date":"2024-07-12","current":4.109685,"twenty":0.932501,"median":3.800901,"eighty":7.207477,"marketCap":103099673},{"date":"2024-07-15","current":4.193863,"twenty":0.932501,"median":3.800901,"eighty":7.194036,"marketCap":105211444},{"date":"2024-08-02","current":4.458422,"twenty":-0.282248,"median":3.785593,"eighty":6.893892,"marketCap":111848438},{"date":"2024-08-09","current":4.330188,"twenty":-0.282248,"median":3.785593,"eighty":6.71397,"marketCap":112034952},{"date":"2024-08-16","current":4.293515,"twenty":-0.282248,"median":3.785593,"eighty":6.684421,"marketCap":111086122},{"date":"2024-08-23","current":4.437385,"twenty":-0.282248,"median":3.785593,"eighty":6.626684,"marketCap":114808456},{"date":"2024-08-30","current":4.443027,"twenty":-0.282248,"median":3.785593,"eighty":6.593741,"marketCap":114954430},{"date":"2024-09-06","current":4.420459,"twenty":-0.282248,"median":3.785593,"eighty":6.572485,"marketCap":114370534},{"date":"2024-09-13","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.489344,"marketCap":112764822},{"date":"2024-09-20","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.439122,"marketCap":112764822},{"date":"2024-09-27","current":4.403533,"twenty":-0.282248,"median":3.785593,"eighty":6.403286,"marketCap":113932613},{"date":"2024-10-04","current":4.45149,"twenty":-0.282248,"median":3.785593,"eighty":6.389947,"marketCap":115173391},{"date":"2024-10-11","current":4.474057,"twenty":-0.282248,"median":3.785593,"eighty":6.366105,"marketCap":115757286},{"date":"2024-10-18","current":4.327367,"twenty":-0.282248,"median":3.785593,"eighty":6.321904,"marketCap":111961965},{"date":"2024-10-25","current":4.321725,"twenty":-0.282248,"median":3.785593,"eighty":6.261802,"marketCap":111815992},{"date":"2024-10-31","current":4.27941,"twenty":-0.282248,"median":3.785593,"eighty":6.240491,"marketCap":110721187},{"date":"2024-11-08","current":4.441959,"twenty":-0.282549,"median":3.784012,"eighty":6.202291,"marketCap":116779104},{"date":"2024-11-15","current":4.397133,"twenty":-0.282549,"median":3.784012,"eighty":6.149605,"marketCap":115600635},{"date":"2024-11-22","current":4.560596,"twenty":-0.282549,"median":3.784012,"eighty":6.139391,"marketCap":119898057},{"date":"2024-11-29","current":4.732231,"twenty":-0.282549,"median":3.784012,"eighty":6.120618,"marketCap":124410349},{"date":"2024-12-06","current":4.80034,"twenty":-0.282549,"median":3.784012,"eighty":6.102487,"marketCap":126200941},{"date":"2024-12-13","current":4.66957,"twenty":-0.282549,"median":3.784012,"eighty":6.088852,"marketCap":122763004},{"date":"2024-12-20","current":4.171011,"twenty":-0.282549,"median":3.784012,"eighty":6.078382,"marketCap":109655869},{"date":"2024-12-27","current":4.405306,"twenty":-0.282549,"median":3.784012,"eighty":6.067331,"marketCap":115815506},{"date":"2025-01-03","current":4.489762,"twenty":-0.282549,"median":3.784012,"eighty":6.059453,"marketCap":118035841},{"date":"2025-01-10","current":4.745853,"twenty":-0.28285,"median":3.782431,"eighty":6.049147,"marketCap":124768467},{"date":"2025-01-17","current":4.822135,"twenty":-0.28285,"median":3.782431,"eighty":6.037025,"marketCap":126773931},{"date":"2025-01-24","current":4.890244,"twenty":-0.28285,"median":3.782431,"eighty":6.035572,"marketCap":128564523},{"date":"2025-01-31","current":4.794891,"twenty":-0.28285,"median":3.782431,"eighty":6.016756,"marketCap":126057694},{"date":"2025-02-07","current":5.012841,"twenty":-0.28285,"median":3.782431,"eighty":6.002169,"marketCap":131787589},{"date":"2025-02-14","current":5.165406,"twenty":-0.28285,"median":3.782431,"eighty":5.999213,"marketCap":135798516},{"date":"2025-02-21","current":5.375182,"twenty":-0.28285,"median":3.782431,"eighty":5.991941,"marketCap":141313540},{"date":"2025-02-28","current":5.6231,"twenty":-0.28285,"median":3.782431,"eighty":5.970126,"marketCap":147831296},{"date":"2025-03-07","current":5.080493,"twenty":-0.283753,"median":3.782268,"eighty":5.951081,"marketCap":148690780},{"date":"2025-03-14","current":5.481842,"twenty":-0.283753,"median":3.782268,"eighty":5.922788,"marketCap":160437065},{"date":"2025-03-21","current":11.366901,"twenty":-0.283753,"median":3.788005,"eighty":5.926495,"marketCap":332675095},{"date":"2025-03-28","current":5.041233,"twenty":-0.283753,"median":3.800901,"eighty":5.92678,"marketCap":147541761},{"date":"2025-04-04","current":4.869586,"twenty":-0.283753,"median":3.829511,"eighty":5.92678,"marketCap":142518184},{"date":"2025-04-11","current":4.150082,"twenty":-0.28285,"median":3.860508,"eighty":5.926495,"marketCap":121460451},{"date":"2025-04-17","current":4.12892,"twenty":-0.28285,"median":3.878196,"eighty":5.926495,"marketCap":120841106},{"date":"2025-04-25","current":4.180649,"twenty":-0.283753,"median":3.918344,"eighty":5.92678,"marketCap":122355061},{"date":"2025-05-02","current":5.432928,"twenty":-0.283753,"median":3.947302,"eighty":5.92678,"marketCap":128135615},{"date":"2025-05-09","current":5.37749,"twenty":-0.281646,"median":3.98112,"eighty":5.92678,"marketCap":126828109},{"date":"2025-05-16","current":5.476695,"twenty":2.250745,"median":4.028927,"eighty":5.92678,"marketCap":129167857},{"date":"2025-05-23","current":5.249107,"twenty":2.332489,"median":4.112248,"eighty":5.92678,"marketCap":123800199},{"date":"2025-05-30","current":5.567147,"twenty":2.374551,"median":4.140676,"eighty":5.92678,"marketCap":131301156},{"date":"2025-06-06","current":5.307463,"twenty":2.40471,"median":4.185579,"eighty":5.92678,"marketCap":125176522},{"date":"2025-06-12","current":5.224981,"twenty":2.413836,"median":4.196466,"eighty":5.92678,"marketCap":123231183}],"updateTime":1749855339677}}}